Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandre Harari

Showing results (81-90 of 130) with videos related to

Pageof 13
Sort By:
Immunity|October 10, 2023
Machine learning methods and harmonized datasets improve immunogenic neoantigen predictionMarkus Müller, Florian Huber, Marion Arnaud, et al.
Journal for Immunotherapy of Cancer|August 28, 2020
Guillain-Barré syndrome after adoptive cell therapy with tumor-infiltrating lymphocytesAngela Orcurto, Andreas Hottinger, Benita Wolf, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|August 19, 2024
Predicting Antigen-Specificities of Orphan T Cell Receptors from Cancer Patients with TCRpcDistMarta A S Perez, Johanna Chiffelle, Sara Bobisse, et al.
The Journal of Experimental Medicine|May 31, 2007
Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8(+) T cell responsesMelissa L Precopio, Michael R Betts, Janie Parrino, et al.
Journal of Translational Medicine|November 28, 2019
A Phase I/II trial comparing autologous dendritic cell vaccine pulsed either with personalized peptides (PEP-DC) or with tumor lysate (OC-DC) in patients with advanced high-grade ovarian serous carcinomaApostolos Sarivalasis, Caroline Boudousquié, Klara Balint, et al.
European Journal of Cancer (Oxford, England : 1990)|June 27, 2020
Quantitative and qualitative impairments in dendritic cell subsets of patients with ovarian or prostate cancerBeatris Mastelic-Gavillet, Apostolos Sarivalasis, Leyder Elena Lozano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2019
High-throughput Screening of Human Tumor Antigen-specific CD4 T Cells, Including Neoantigen-reactive T CellsCarla Costa-Nunes, Amélie Cachot, Sara Bobisse, et al.
Nature Medicine|February 22, 2011
Dominant TNF-α+ Mycobacterium tuberculosis-specific CD4+ T cell responses discriminate between latent infection and active diseaseAlexandre Harari, Virginie Rozot, Felicitas Bellutti Enders, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 2, 2014
Combined use of Mycobacterium tuberculosis-specific CD4 and CD8 T-cell responses is a powerful diagnostic tool of active tuberculosisVirginie Rozot, Amelio Patrizia, Selena Vigano, et al.
AIDS Research and Human Retroviruses|February 12, 2016
Effect of Schistosoma mansoni Infection on Innate and HIV-1-Specific T-Cell Immune Responses in HIV-1-Infected Ugandan Fisher FolkAndrew Ekii Obuku, Gershim Asiki, Andrew Abaasa, et al.
Pageof 13

Showing results (81-90 of 130) with videos related to

Sort By:
Pageof 13
Immunity|October 10, 2023
Machine learning methods and harmonized datasets improve immunogenic neoantigen predictionMarkus Müller, Florian Huber, Marion Arnaud, et al.
Journal for Immunotherapy of Cancer|August 28, 2020
Guillain-Barré syndrome after adoptive cell therapy with tumor-infiltrating lymphocytesAngela Orcurto, Andreas Hottinger, Benita Wolf, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|August 19, 2024
Predicting Antigen-Specificities of Orphan T Cell Receptors from Cancer Patients with TCRpcDistMarta A S Perez, Johanna Chiffelle, Sara Bobisse, et al.
The Journal of Experimental Medicine|May 31, 2007
Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8(+) T cell responsesMelissa L Precopio, Michael R Betts, Janie Parrino, et al.
Journal of Translational Medicine|November 28, 2019
A Phase I/II trial comparing autologous dendritic cell vaccine pulsed either with personalized peptides (PEP-DC) or with tumor lysate (OC-DC) in patients with advanced high-grade ovarian serous carcinomaApostolos Sarivalasis, Caroline Boudousquié, Klara Balint, et al.
European Journal of Cancer (Oxford, England : 1990)|June 27, 2020
Quantitative and qualitative impairments in dendritic cell subsets of patients with ovarian or prostate cancerBeatris Mastelic-Gavillet, Apostolos Sarivalasis, Leyder Elena Lozano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2019
High-throughput Screening of Human Tumor Antigen-specific CD4 T Cells, Including Neoantigen-reactive T CellsCarla Costa-Nunes, Amélie Cachot, Sara Bobisse, et al.
Nature Medicine|February 22, 2011
Dominant TNF-α+ Mycobacterium tuberculosis-specific CD4+ T cell responses discriminate between latent infection and active diseaseAlexandre Harari, Virginie Rozot, Felicitas Bellutti Enders, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 2, 2014
Combined use of Mycobacterium tuberculosis-specific CD4 and CD8 T-cell responses is a powerful diagnostic tool of active tuberculosisVirginie Rozot, Amelio Patrizia, Selena Vigano, et al.
AIDS Research and Human Retroviruses|February 12, 2016
Effect of Schistosoma mansoni Infection on Innate and HIV-1-Specific T-Cell Immune Responses in HIV-1-Infected Ugandan Fisher FolkAndrew Ekii Obuku, Gershim Asiki, Andrew Abaasa, et al.
Pageof 13